Back to
Clear Street Group Inc.
ARTL2 quarters
Position history for
Clear Street Group Inc.'s holdings in ARTELO BIOSCIENCES INC
No. Clear Street Group exited its ARTL (Artelo Biosciences) position in Q2 2026. Its Q1 2026 13F listed 100 shares worth $758. Clear Street Group first reported ARTL in Q1 2026 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$758
Total Shares Change
-100
Quarter-by-Quarter History
Other major holders of ARTL: JANE STREET GROUP, LLC, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD FIDUCIARY TRUST CO, CITIGROUP INC